RHY Rhythm Biosciences Limited
Healthcare · Diagnostics & Research
· website
$0.08
52wk 0.06 – 0.28
Overall
—
Value
—
Growth
—
Health
—
Quality
—
Momentum
—
Dividend
—
Price
About Rhythm Biosciences Limited
Rhythm Biosciences Limited, a medical diagnostics company, provides blood tests for the detection of cancers in Australia and the United States. It offers ColoSTAT, a blood test for the early detection of colorectal cancer; and geneType, a personalized predictive test for predicting risk of chronic disease development. The company was incorporated in 2017 and is headquartered in Parkville, Australia.
Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$28.66M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
-0.02
Dividend yield
—
Payout ratio
0.0%
Beta
0.41
EV / EBITDA
-3.93
Price / Book
13.50
ROE
-190.1%
Operating margin
-136.7%
Net margin
0.0%
Total cash
$1.73M
Total debt
$262,444
Current ratio
2.31
Debt / Equity
0.12
Free cash flow
$-3.93M
Avg volume
346,387
Latest annual results
(FY ending 30 Jun 2025)
- Revenue—
- Gross profit—
- Operating income—
- Net income—
- Diluted EPS-0.01
- Free cash flow—
- Net debt—